Journals / Hacettepe Journal of Biology and Chemistry / 2019 / Cilt: 47 - Sayı: 3

The Influence of the Myricetin on the Liver, Kidney, Spleen and Some Endocrine Glands of Male Rats at Prepubertal Period

Pages
317–326
Publication Date
2019-10-23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study demonstrated that orally gavages myricetin caused adverse effects on male liver, kidney, spleen and endocrine glands, during peripubertal period to pubertal period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, the effects of myricetin exposure to rats from postnatal day (PND) 23 to 53 at various doses were investigated.
📊
Key Findings & Data:Group of rats were treated with myricetin 25 and 50 mg/kg/day in a suspension of corn oil.
💡
Conclusion & Impact:This study demonstrated that orally gavages myricetin caused adverse effects on male liver, kidney, spleen and endocrine glands, during peripubertal period to pubertal period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Phytoestrogen · myricetin · endocrine glands

Abstract

In this study, the effects of myricetin exposure to rats from postnatal day (PND) 23 to 53 at various doses were investigated. The male rats were divided into five groups and each group consisted of six animals. Group of rats were treated with myricetin 25 and 50 mg/kg/day in a suspension of corn oil. Positive control males were received gavage orally with 17α-ethinyl estradiol 0.7 and 7 µg /kg /body weight day and control males were received corn oil. End of the study, weights of liver, kidney, spleen, pancreas, thymus and adrenal gland were measured. Organ/body weight ratios were calculated and tissue sections were examined histologically. In liver, the TUNEL method was applied and evaluated. In results, absolute liver weights were decreased statistically in 0.7 and 7 µg/kg/day etinil estradiol and 50 mg/kg/day myricetin treatment groups, compared with the oil control group. Histopathological examination of the liver, kidney and spleen revealed significantly increased frequency of congestion, cell degeneration and mononuclear cell infiltration when compared with the control group. Also myricetin dose groups, the apoptotic cells were increased. This study demonstrated that orally gavages myricetin caused adverse effects on male liver, kidney, spleen and endocrine glands, during peripubertal period to pubertal period.

🔖

Cite This Article

BARLAS, N., OFLAMAZ, A. O. (2019). The Influence of the Myricetin on the Liver, Kidney, Spleen and Some Endocrine Glands of Male Rats at Prepubertal Period. Hacettepe Journal of Biology and Chemistry, Cilt: 47 - Sayı: 3, 317–326. https://ajindex.com/articles/255825

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Referans 1 A. Okan, N. Barlas, G. Karabulut, Investigation of effects of myricetin on thyroid-gonadal axis of male rats at prepubertal period. Environ. Tox. Pharmacol., 40(2015) (1), 268-279. Referans 2. G.D. Castro, N.Q. Leanordo, M.E. Maciel, J.A. Castro, Preventive effects of plant polyphenols in the promotion of mammary cancer and testicular damage induced by alcohol drinking, Chapter 88, Polyphenols in Human Health and Dis. (2014) 1181-1190. Referans 3. A.V. Sirotkin, A.H. Harrath, Phytoestrogens and their effects. Europ. J. Pharmacol., 741 (2014) 230-236. Referans 4. J.A. Ross, C.M. Kasum, Dietary flavonoids: bioavailability, metabolic effects, and safety, Ann. Rev. Nutritio., 22 (2002) 19-34. Referans 5. F. Sun, X.Y. Zheng, J. Ye, T.T. Wu, J. Wang, W. Chen, Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo, Nutr. Cancer., 64 (2012) 599–606.Referans 6. S.K. Jung, K.W. Lee, S. Byun, N.J. Kang, S.H. Lim, Y.S. Heo, A.M. Bode, G.T. Bowden, H.J Lee, Z.Dong, Myricetin suppresses UVB-induced skin cancer by targeting Fyn, Cancer Res., 68 (2008) 6021–6029. Referans7. C.J. Weng, G.C. Yen, Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities, Cancer Metas. Rev., 31 (2012) 323–351. Referans 8. S. Zhang, L. Wang, H. Liu, G. Zhao and L. Ming, Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cell, Diagnos. Pathol., 9 (2014) 68. Referans 9. J.P.E. Spencer, Flavonoids: modulators of brain function? British J Nutrit., 99 (2008) E-Suppl. 1, ES60–ES77. Referans 10. R. Henneberg, M. Fleith, O. Aline, E.F. Furman, P. Hermann, A.J. Nascimento, M.SS. Leonart, Protective effect of flavonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea, Revis. Brasil. Hematol. Hemoterapia., 35(1) (2013) 52-55. Referans 11. R. Bertin, Z. Chen, R. Marin, M. Donati, A. Feltrinelli, M. Montopoli, S. Zambon, E. Manzato, G. Froldi, Activity of myricetin and other plant-derived polyhydroxyl compounds in human LDL and human vascular endothelial cells against oxidative stress, Biomed. Pharmac., 82 (2016) 472-478. Referans 12. M. Mu, P. An, Q. Wu, X. Shen, D. Shao, H. Wang, Y. Zhang, S. Zhang, H. Yao, J. Min, F. Wang, The dietary flavonoid myricetin regulates iron homeostasis by suppressing hepcidin expression, The J. Nutrit. Biochem., 30 (2016) 53-61. Referans 13. H. Pan, Q. Hu